Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
Khulood Muhammad Sayed1, Engy Mohammed Mostafa1, Amr Mounir1
1The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
Clinical Ophthalmology (Auckland, N.Z.)
|December 12, 2019
Summary
Bimatoprost eye drops significantly increase eyelash length and thickness in rabbits. Ultrastructural analysis revealed more hairs per follicle and enhanced pigmentation, suggesting potential prophylactic use against chemotherapy-induced eyelash loss.
Area of Science:
- Ophthalmology
- Dermatology
- Pharmacology
Background:
- Bimatoprost is a prostaglandin analog used to treat glaucoma.
- Its cosmetic effect of eyelash growth is well-documented.
- The precise mechanism of bimatoprost on eyelash follicles requires further elucidation.
Purpose of the Study:
- To investigate the ultrastructural changes in rabbit eyelash follicles following topical bimatoprost application.
- To understand the cellular and histological mechanisms behind bimatoprost-induced eyelash enhancement.
Main Methods:
- Clinically healthy male rabbits (n=15) received daily topical bimatoprost (0.03%) in one eye for 4 weeks, with the contralateral eye serving as a control.
- Eyelash length was measured pre- and post-treatment.
- Eyelid tissues were analyzed using light and electron microscopy.
Main Results:
- Bimatoprost treatment significantly increased eyelash length compared to controls (11.60±0.46 mm vs. 9.75±0.33 mm).
- Histological examination revealed thickened epidermis and the presence of multiple (two) hairs emerging from a single follicle in treated eyes.
- Electron microscopy showed prominent nucleoli and melanin granules within cortical cells (Cx) and a heavily keratinized Henle's layer.
Conclusions:
- Bimatoprost induces not only increased eyelash length, thickness, and pigmentation but also a higher density of stronger, more robust eyelashes.
- These changes, observed within one month, suggest bimatoprost's potential as a prophylactic agent against chemotherapy-induced madarosis (eyelash loss).
- Further research is warranted to explore bimatoprost's role in preventing chemotherapy-related eyelash shedding.


